Crossing the Chasm: Clinical to Commercial Scale-up of Gene Therapies


120 minutes

Speakers

Kelley Rogers, PhD - Technical Program Manager, NIIMBL at NIST OMA
Kevin Slatkavitz, PhD - MassBio Co-Chair for DRUGMAN & SUPPLY Working Group President and Founder, ThinkQuality, LLC
Peter Marks, MD, PhD - Director of the Center for Biologics Evaluation and Research (CBER) at FDA
Rod Rietze, PhD - Past Director of Strategic Development and Innovation at Novartis Pharmaceuticals
Scott McMilian, PhD - COO, uniQure
Susan Abu-Absi, PhD - Senior Vice President, Pharmaceutical Development & Technology, bluebird bio